“…Screening DPP-4 inhibitors for treating diabetes is a recently developing field (since 2006), when a study reported that DPP-4 might regulate insulin sensitivity via degradation of GLP-1 [22]. Up to now, few natural DPP-4 inhibitors have been reported [23] From plant origin, DPP-4 inhibitory activities of kaempferol and derivatives, linustatins, chrysin, stigmasterol, emodin, lupeol, mangiferin, vitisins, and soybean hydrolysates were all validated via direct enzymatic assay and in vivo hypoglycemic analysis [24,25,26,27,28,29,30,31]. Moreover, the methanolic extracts of Ficus benghalensis , Syzigium cumini , Ocimum sanctum , and Eucalyptus sp.…”